Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
2019-01-01 Mazzaferro, V; El-Rayes, Bf; Droz Dit Busset, M; Cotsoglou, C; Harris, Wp; Damjanov N, ; Masi, G; Rimassa, L; Personeni, N; Braiteh, F; Zagonel, V; Papadopoulos, Kp; Hall, T; Wang, Y; Schwartz, B; Kazakin, J; Bhoori, S; De Braud, F; Shaib, Wl
Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing?
2007-01-01 Personeni, N.
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery : a retrospective study
2017-01-01 Comito, T.; Cozzi, L.; Zerbi, A.; Franzese, C.; Clerici, E.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.; Fogliata, A.; Mancosu, P.; Tomatis, S.; Carnaghi, C.; Personeni, N.; Santoro, A.; Scorsetti, M.
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine
2019-01-01 Rimassa, L; Personeni, N; Aghemo, A; Lleo, A
Shaping the landscape of immune oncology in hepatocellular carcinoma
2018-01-01 Personeni, N; Rimassa, L
Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives
2021-01-01 Personeni, Nicola; Smiroldo, Valeria; Giunta, Emilio Francesco; Prete, Maria Giuseppina; Rimassa, Lorenza; Bregni, Giacomo; Sclafani, Francesco
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
2017-01-01 Personeni, N.; Giordano, L.; Abbadessa, G.; Porta, C.; Borbath, I.; Daniele, B.; Van Laethem, J.; Van Vlierberghe, H.; Trojan, J.; De Toni, E. N.; Gasbarrini, A.; Lencioni, M.; Lamar, M. E.; Wang, Y.; Shuster, D.; Schwartz, B.; Santoro, A.; Rimassa, L.
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough?
2011-01-01 Personeni, N.; Torzilli, G.; Santoro, A.
Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma
2021-01-01 D'Alessio, Antonio; Cammarota, Antonella; Zanuso, Valentina; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach
2014-01-01 Comito, T; Cozzi, L; Clerici, E; Campisi, Mc; Liardo, Rle; Navarria, P; Ascolese, A; Tozzi, A; Iftode, C; De Rose, F; Villa, E; Personeni, N; Rimassa, L; Santoro, A; Fogliata, A; Mancosu, P; Tomatis, S; Scorsetti, M
Tivantinib : a new promising mesenchymal–epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma
2013-01-01 Rimassa, L.; Personeni, N.; Matteo, Simonelli; Santoro, A.
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade
2020-01-01 Pinato, David J; Kaneko, Takahiro; Saeed, Anwaar; Pressiani, Tiziana; Kaseb, Ahmed; Wang, Yinghong; Szafron, David; Jun, Tomi; Dharmapuri, Sirish; Naqash, Abdul Rafeh; Muzaffar, Mahvish; Navaid, Musharraf; Lee, Chieh-Ju; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Nimkar, Neil; Bettinger, Dominik; Hildebrand, Hannah; Abugabal, Yehia I; Ang, Celina; Marron, Thomas U; Khan, Uqba; Personeni, Nicola; Rimassa, Lorenza; Huang, Yi-Hsiang
Tivantinib for hepatocellular carcinoma
2015-01-01 Rimassa, L; Personeni, N; Santoro, A
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials
2022-01-01 Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Bozzarelli, Silvia; Personeni, Nicola; Rimassa, Lorenza
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study
2017-01-01 Comito, T.; Cozzi, L.; Clerici, E.; Franzese, C.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Tronconi, M.; De Rose, F.; Franceschini, D.; Ascolese, A.; Fogliata, A.; Tomatis, S.; Santoro, A.; Zerbi, A.; Scorsetti, M.
Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study
2008-01-01 Personeni, N.; Fieuws, S.; Piessevaux, H.; De Hertogh, G.; De Schutter, J.; Biesmans, B.; De Roock, W.; Capoen, A.; Debiec Rychter, M.; Van Laethem, J.; Peeters, M.; Humblet, Y.; Van Cutsem, E.; Tejpar, S.
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer
2013-01-01 Sclafani, F.; Incarbone, M.; Rimassa, L.; Personeni, N.; Giordano, L.; Alloisio, M.; Santoro, A.
Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND)
2019-01-01 Bozzarelli, S; Rimassa, L; Giordano, L; Sala, S; Tronconi, Mc; Pressiani, T; Smiroldo, V; Prete, Mg; Spaggiari, P; Personeni, N; Santoro, A
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
2022-01-01 Fulgenzi, Claudia Angela Maria; Cheon, Jaekyung; D'Alessio, Antonio; Nishida, Naoshi; Ang, Celina; Marron, Thomas U; Wu, Linda; Saeed, Anwaar; Wietharn, Brooke; Cammarota, Antonella; Pressiani, Tiziana; Personeni, Nicola; Pinter, Matthias; Scheiner, Bernhard; Balcar, Lorenz; Napolitano, Andrea; Huang, Yi-Hsiang; Phen, Samuel; Naqash, Abdul Rafeh; Vivaldi, Caterina; Salani, Francesca; Masi, Gianluca; Bettinger, Dominik; Vogel, Arndt; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Galle, Peter R; Kudo, Masatoshi; Rimassa, Lorenza; Singal, Amit G; Sharma, Rohini; Cortellini, Alessio; Gaillard, Vincent E; Chon, Hong Jae; Pinato, David James
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma
2022-01-01 Muhammed, Ambreen; Fulgenzi, Claudia Angela Maria; Dharmapuri, Sirish; Pinter, Matthias; Balcar, Lorenz; Scheiner, Bernhard; Marron, Thomas U; Jun, Tomi; Saeed, Anwaar; Hildebrand, Hannah; Muzaffar, Mahvish; Navaid, Musharraf; Naqash, Abdul Rafeh; Gampa, Anuhya; Ozbek, Umut; Lin, Junk-Yi; Perone, Ylenia; Vincenzi, Bruno; Silletta, Marianna; Pillai, Anjana; Wang, Yinghong; Khan, Uqba; Huang, Yi-Hsiang; Bettinger, Dominik; Abugabal, Yehia I; Kaseb, Ahmed; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza; Nishida, Naoshi; Di Tommaso, Luca; Kudo, Masatoshi; Vogel, Arndt; Mauri, Francesco A; Cortellini, Alessio; Sharma, Rohini; D'Alessio, Antonio; Ang, Celina; Pinato, David J
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma | 1-gen-2019 | Mazzaferro, V; El-Rayes, Bf; Droz Dit Busset, M; Cotsoglou, C; Harris, Wp; Damjanov N, ; Masi, G; Rimassa, L; Personeni, N; Braiteh, F; Zagonel, V; Papadopoulos, Kp; Hall, T; Wang, Y; Schwartz, B; Kazakin, J; Bhoori, S; De Braud, F; Shaib, Wl | |
| Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing? | 1-gen-2007 | Personeni, N. | |
| Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery : a retrospective study | 1-gen-2017 | Comito, T.; Cozzi, L.; Zerbi, A.; Franzese, C.; Clerici, E.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.; Fogliata, A.; Mancosu, P.; Tomatis, S.; Carnaghi, C.; Personeni, N.; Santoro, A.; Scorsetti, M. | |
| The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine | 1-gen-2019 | Rimassa, L; Personeni, N; Aghemo, A; Lleo, A | |
| Shaping the landscape of immune oncology in hepatocellular carcinoma | 1-gen-2018 | Personeni, N; Rimassa, L | |
| Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives | 1-gen-2021 | Personeni, Nicola; Smiroldo, Valeria; Giunta, Emilio Francesco; Prete, Maria Giuseppina; Rimassa, Lorenza; Bregni, Giacomo; Sclafani, Francesco | |
| Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma | 1-gen-2017 | Personeni, N.; Giordano, L.; Abbadessa, G.; Porta, C.; Borbath, I.; Daniele, B.; Van Laethem, J.; Van Vlierberghe, H.; Trojan, J.; De Toni, E. N.; Gasbarrini, A.; Lencioni, M.; Lamar, M. E.; Wang, Y.; Shuster, D.; Schwartz, B.; Santoro, A.; Rimassa, L. | |
| Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? | 1-gen-2011 | Personeni, N.; Torzilli, G.; Santoro, A. | |
| Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma | 1-gen-2021 | D'Alessio, Antonio; Cammarota, Antonella; Zanuso, Valentina; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza | |
| Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach | 1-gen-2014 | Comito, T; Cozzi, L; Clerici, E; Campisi, Mc; Liardo, Rle; Navarria, P; Ascolese, A; Tozzi, A; Iftode, C; De Rose, F; Villa, E; Personeni, N; Rimassa, L; Santoro, A; Fogliata, A; Mancosu, P; Tomatis, S; Scorsetti, M | |
| Tivantinib : a new promising mesenchymal–epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma | 1-gen-2013 | Rimassa, L.; Personeni, N.; Matteo, Simonelli; Santoro, A. | |
| Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade | 1-gen-2020 | Pinato, David J; Kaneko, Takahiro; Saeed, Anwaar; Pressiani, Tiziana; Kaseb, Ahmed; Wang, Yinghong; Szafron, David; Jun, Tomi; Dharmapuri, Sirish; Naqash, Abdul Rafeh; Muzaffar, Mahvish; Navaid, Musharraf; Lee, Chieh-Ju; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Nimkar, Neil; Bettinger, Dominik; Hildebrand, Hannah; Abugabal, Yehia I; Ang, Celina; Marron, Thomas U; Khan, Uqba; Personeni, Nicola; Rimassa, Lorenza; Huang, Yi-Hsiang | |
| Tivantinib for hepatocellular carcinoma | 1-gen-2015 | Rimassa, L; Personeni, N; Santoro, A | |
| The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials | 1-gen-2022 | Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Bozzarelli, Silvia; Personeni, Nicola; Rimassa, Lorenza | |
| Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study | 1-gen-2017 | Comito, T.; Cozzi, L.; Clerici, E.; Franzese, C.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Tronconi, M.; De Rose, F.; Franceschini, D.; Ascolese, A.; Fogliata, A.; Tomatis, S.; Santoro, A.; Zerbi, A.; Scorsetti, M. | |
| Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study | 1-gen-2008 | Personeni, N.; Fieuws, S.; Piessevaux, H.; De Hertogh, G.; De Schutter, J.; Biesmans, B.; De Roock, W.; Capoen, A.; Debiec Rychter, M.; Van Laethem, J.; Peeters, M.; Humblet, Y.; Van Cutsem, E.; Tejpar, S. | |
| The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer | 1-gen-2013 | Sclafani, F.; Incarbone, M.; Rimassa, L.; Personeni, N.; Giordano, L.; Alloisio, M.; Santoro, A. | |
| Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND) | 1-gen-2019 | Bozzarelli, S; Rimassa, L; Giordano, L; Sala, S; Tronconi, Mc; Pressiani, T; Smiroldo, V; Prete, Mg; Spaggiari, P; Personeni, N; Santoro, A | |
| Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study | 1-gen-2022 | Fulgenzi, Claudia Angela Maria; Cheon, Jaekyung; D'Alessio, Antonio; Nishida, Naoshi; Ang, Celina; Marron, Thomas U; Wu, Linda; Saeed, Anwaar; Wietharn, Brooke; Cammarota, Antonella; Pressiani, Tiziana; Personeni, Nicola; Pinter, Matthias; Scheiner, Bernhard; Balcar, Lorenz; Napolitano, Andrea; Huang, Yi-Hsiang; Phen, Samuel; Naqash, Abdul Rafeh; Vivaldi, Caterina; Salani, Francesca; Masi, Gianluca; Bettinger, Dominik; Vogel, Arndt; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Galle, Peter R; Kudo, Masatoshi; Rimassa, Lorenza; Singal, Amit G; Sharma, Rohini; Cortellini, Alessio; Gaillard, Vincent E; Chon, Hong Jae; Pinato, David James | |
| The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma | 1-gen-2022 | Muhammed, Ambreen; Fulgenzi, Claudia Angela Maria; Dharmapuri, Sirish; Pinter, Matthias; Balcar, Lorenz; Scheiner, Bernhard; Marron, Thomas U; Jun, Tomi; Saeed, Anwaar; Hildebrand, Hannah; Muzaffar, Mahvish; Navaid, Musharraf; Naqash, Abdul Rafeh; Gampa, Anuhya; Ozbek, Umut; Lin, Junk-Yi; Perone, Ylenia; Vincenzi, Bruno; Silletta, Marianna; Pillai, Anjana; Wang, Yinghong; Khan, Uqba; Huang, Yi-Hsiang; Bettinger, Dominik; Abugabal, Yehia I; Kaseb, Ahmed; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza; Nishida, Naoshi; Di Tommaso, Luca; Kudo, Masatoshi; Vogel, Arndt; Mauri, Francesco A; Cortellini, Alessio; Sharma, Rohini; D'Alessio, Antonio; Ang, Celina; Pinato, David J |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista70074
- 7 Altro1
Data di pubblicazione
- In corso di stampa70
- 2020 - 202615407
- 2010 - 201922876
- 2000 - 200918271
- 1990 - 19998867
- 1980 - 19893843
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI916
- Elsevier Ltd721
- Elsevier B.V.608
- MDPI AG496
- Elsevier370
- Springer306
- John Wiley and Sons Inc296
- Springer Science and Business Med...276
- Multidisciplinary Digital Publish...271
- Elsevier Inc.248
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE930
- PLOS ONE375
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- AREA262
- SCIENTIFIC REPORTS259
- INTERNATIONAL JOURNAL OF MOLECULA...186
- DOCTOR. OS183
- ACTA BIOMEDICA179
- NUTRIENTS172
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2896
- Female1591
- Male1487
- Middle Aged900
- Adult893
- Aged756
- Animals651
- Italy580
- Medicine (all)463
- COVID-19447
Lingua
- eng42155
- ita8971
- fre231
- spa121
- ger98
- und58
- enm49
- rus40
- grc32
- por30
Accesso al fulltext
- no fulltext56787
- reserved8055
- open3743
- partially open810
- restricted667
- mixed13